METHOD AND SYSTEM FOR MICROBIOME-DERIVED DIAGNOSTICS AND THERAPEUTICS FOR CONDITIONS ASSOCIATED WITH MICROBIOME TAXONOMIC FEATURES
    81.
    发明申请
    METHOD AND SYSTEM FOR MICROBIOME-DERIVED DIAGNOSTICS AND THERAPEUTICS FOR CONDITIONS ASSOCIATED WITH MICROBIOME TAXONOMIC FEATURES 审中-公开
    用微生物衍生的诊断方法和系统和与微生物特征特征相关的条件的治疗方法

    公开(公告)号:US20160224749A1

    公开(公告)日:2016-08-04

    申请号:US15098174

    申请日:2016-04-13

    Applicant: uBiome, Inc.

    Abstract: A method for at least one of characterizing, diagnosing, and treating a condition associated with microbiome taxonomic features in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the condition based upon features extracted from at least one of the microbiome composition dataset and the microbiome functional diversity dataset; based upon the characterization, generating a therapy model configured to correct the condition; and at an output device associated with the subject, promoting a therapy to the subject based upon the characterization and the therapy model.

    Abstract translation: 用于表征,诊断和治疗与至少一个受试者中的微生物组分类特征有关的病症中的至少一种的方法,所述方法包括:从受试者群体接收聚集的一组生物样品; 为受试者群体生成微生物组合数据集和微生物群功能分集数据集中的至少一个; 基于从至少一个微生物组合数据集和微生物组合功能分集数据集中提取的特征产生条件的表征; 基于所述表征,产生被配置为校正所述状况的治疗模型; 并且在与受试者相关联的输出装置处,基于表征和治疗模型促进对受试者的治疗。

    Method and system for diagnostic testing

    公开(公告)号:US10415105B2

    公开(公告)日:2019-09-17

    申请号:US15198818

    申请日:2016-06-30

    Applicant: uBiome, Inc.

    Abstract: An embodiment of a method for diagnostic testing includes: providing a sampling kit to a subject, the sampling kit including a sample container for reception of a sample from a collection site of the subject; receiving the sample from the subject; generating a microbiome sequence dataset based upon sequencing nucleic acid content of a microorganism portion of the sample; detecting a presence of a set of microbiome targets; generating a diagnostic analysis based on the detected set of microbiome targets; generating a therapy recommendation based on the set of microbiome targets; and promoting the therapy recommendation in coordination with presenting information derived from the diagnostic analysis.

    Method and system for microbiome-derived diagnostics and therapeutics for locomotor system conditions

    公开(公告)号:US10409955B2

    公开(公告)日:2019-09-10

    申请号:US15098222

    申请日:2016-04-13

    Applicant: uBiome, Inc.

    Abstract: A method for at least one of characterizing, diagnosing, and treating a locomotor system condition in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the locomotor system condition based upon features extracted from at least one of the microbiome composition dataset and the microbiome functional diversity dataset; based upon the characterization, generating a therapy model configured to correct the locomotor system condition; and at an output device associated with the subject, promoting a therapy to the subject based upon the characterization and the therapy model.

    Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues

    公开(公告)号:US10360348B2

    公开(公告)日:2019-07-23

    申请号:US15621445

    申请日:2017-06-13

    Applicant: uBiome, Inc.

    Abstract: A method for at least one of characterizing, diagnosing and treating a neurological health issue in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the neurological health issue based upon features extracted from at least one of the microbiome composition dataset and the microbiome functional diversity dataset; based upon the characterization, generating a therapy model configured to correct the neurological health issue; and at an output device associated with the subject, promoting a therapy to the subject based upon the characterization and the therapy model.

    Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues

    公开(公告)号:US10360347B2

    公开(公告)日:2019-07-23

    申请号:US15621398

    申请日:2017-06-13

    Applicant: uBiome, Inc.

    Abstract: A method for at least one of characterizing, diagnosing and treating a neurological health issue in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the neurological health issue based upon features extracted from at least one of the microbiome composition dataset and the microbiome functional diversity dataset; based upon the characterization, generating a therapy model configured to correct the neurological health issue; and at an output device associated with the subject, promoting a therapy to the subject based upon the characterization and the therapy model.

    Method and system for microbiome-derived diagnostics

    公开(公告)号:US10360346B2

    公开(公告)日:2019-07-23

    申请号:US15606824

    申请日:2017-05-26

    Applicant: uBiome, Inc.

    Abstract: A method for diagnosing and treating an immune microbial dysfunction in a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the immune microbial dysfunction based upon features extracted from at least one of the microbiome composition dataset and the microbiome functional diversity dataset, wherein the characterization is diagnostic of at least one of Crohn's disease, inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), ulcerative colitis, and celiac disease; based upon the characterization, generating a therapy model configured to correct the immune microbial dysfunction; and at an output device associated with the subject, promoting a therapy to the subject based upon the characterization and the therapy model.

Patent Agency Ranking